Peptide therapy is coming.
Get first access.
The FDA reviews BPC-157, Thymosin Alpha-1, TB-500, and Semax for restored availability in July 2026. Complete your free assessment now and be first in line when we launch.
Join the Waitlist →
How it works

Complete the free assessment
A 2-minute intake questionnaire. No cost, no obligation.

A licensed provider reviews your intake
At launch, a physician or NP will review your responses and determine if you are a good candidate for peptide therapy.

Receive your therapy at home
If approved, your peptide therapy is compounded and shipped directly to your door with free tracked shipping.
Our treatments
All treatments are physician-supervised and compounded at PCAB-accredited pharmacies.

BPC-157
Joint pain, tissue healing, gut health, and post-injury recovery. One of the most researched peptides for accelerated healing.
- ✓ Tissue & tendon repair
- ✓ Gut lining support
- ✓ Inflammation reduction
- ✓ Post-surgery recovery
Starting at $[TBD]/mo if prescribed
Get Started →
Thymosin Alpha-1
Immune modulation, post-illness recovery, and anti-aging support. Clinically studied in over 40 countries for immune optimization.
- ✓ Immune system optimization
- ✓ Post-illness recovery
- ✓ Anti-aging support
- ✓ Chronic fatigue support
Starting at $[TBD]/mo if prescribed
Get Started →
TB-500
Cell migration, tissue regeneration, and systemic healing. Clinically studied for accelerating recovery from injury and reducing chronic inflammation.
- ✓ Muscle & tissue regeneration
- ✓ Wound healing support
- ✓ Chronic inflammation relief
- ✓ Flexibility & mobility
Starting at $[TBD]/mo if prescribed
Get Started →
Semax
Neuroprotection, mental clarity, and cognitive enhancement. Originally developed for stroke recovery, now studied for focus and memory optimization.
- ✓ Focus & mental clarity
- ✓ Memory support
- ✓ Neuroprotection
- ✓ Mood & stress resilience
Starting at $[TBD]/mo if prescribed
Get Started →Be first when peptide therapy launches.
Join the waitlist today. No commitment. Just first access.
Join the Waitlist →